Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Effects of Statins and Exercise on Physiological Health Markers and Quality of Life in Patients With Dyslipidaemia
NCT06841536Completed
- Sponsor
- University of the Faroe Islands
- Start
- May 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of atorvastatin in dyslipidemia (4 arms), sponsored by University of the Faroe Islands. Primary endpoint: Citrate synthase maximal activity at 12 weeks. Started May 2025; status: completed.
02
Drugs
atorvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT06841536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06841536.